A Review of Gene Therapy for Inherited Retinal Disease

Start Course

Please join Paul Yang, MD, PhD, assistant professor in ophthalmic genetics and ocular immunology at Casey Eye Institute, Oregon Health & Science University, for a continuing medical education (CME and COPE) course on gene therapies for inherited retinal diseases (IRDs). During this one-hour webinar, Dr. Yang will discuss emerging gene therapies that may provide hope for people with IRDs such as retinitis pigmentosa, Stargardt disease, Usher syndrome, and Leber congenital amaurosis.

This course titled, A Review of Gene Therapy for Inherited Retinal Disease, will enable eye care professionals to:

  • Describe gene therapy approaches to IRD patients
  • Order genetic testing for IRD patients
  • Discuss clinical trials for emerging gene therapies
  • Identify patients potentially eligible for gene therapy and related clinical trials

Dr. Yang will also discuss how gene therapies work, options for genetic testing of patients, clinical trials, and which patients may qualify for voretigene neparvovec, the first FDA-approved gene therapy for the eye or an inherited condition.

Thursday, June 9, 2022
7:00 - 8:00 PM EDT

1 AMA PRA Category 1 Credit™ and 1 hour of COPE Credit

This course is offered free of charge.

Jointly provided by the Postgraduate Institute for Medicine and the Foundation Fighting Blindness.